Hangzhou Biotest Biotech Co.,Ltd. (688767.SS)
CNY 39.21
(-1.68%)
CNY 39.21
(-1.68%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 105.69 Million CNY | 63.36% |
| 2022 | 196.3 Million CNY | 38.19% |
| 2021 | 142.05 Million CNY | 30.25% |
| 2020 | 109.06 Million CNY | 101.23% |
| 2019 | 54.19 Million CNY | 29.96% |
| 2018 | 41.7 Million CNY | 17.63% |
| 2017 | 35.45 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 44.03 Million CNY | 33.67% |
| 2024 Q3 | 40.83 Million CNY | -10.23% |
| 2024 Q1 | 32.94 Million CNY | -10.18% |
| 2023 Q2 | 38.07 Million CNY | 41.1% |
| 2023 FY | 320.67 Million CNY | 63.36% |
| 2023 Q4 | 36.68 Million CNY | 7.08% |
| 2023 Q3 | 34.25 Million CNY | -10.04% |
| 2023 Q1 | 26.98 Million CNY | -32.87% |
| 2022 Q3 | 42.08 Million CNY | -42.3% |
| 2022 Q1 | 41.08 Million CNY | 55.65% |
| 2022 Q2 | 72.93 Million CNY | 77.53% |
| 2022 FY | 196.3 Million CNY | 38.19% |
| 2022 Q4 | 40.2 Million CNY | -4.47% |
| 2021 FY | 142.05 Million CNY | 30.25% |
| 2021 Q4 | 26.39 Million CNY | -33.04% |
| 2021 Q3 | 39.41 Million CNY | -70.67% |
| 2021 Q2 | 134.41 Million CNY | 161.54% |
| 2021 Q1 | -218.4 Million CNY | -748.99% |
| 2020 FY | 109.06 Million CNY | 101.23% |
| 2020 Q4 | 33.65 Million CNY | 18.32% |
| 2020 Q3 | 28.44 Million CNY | 375.45% |
| 2020 Q2 | -10.32 Million CNY | 72.31% |
| 2020 Q1 | -37.29 Million CNY | 0.0% |
| 2019 FY | 54.19 Million CNY | 29.96% |
| 2018 FY | 41.7 Million CNY | 17.63% |
| 2017 FY | 35.45 Million CNY | 0.0% |